Dual-action breast cancer compounds aim to overcome common drug-resistance issues
Oxygen-delivering hydrogel accelerates diabetic wound healing
30 August 2021Remote learning shown to be effective for preparing clinicians as wheelchair-skills trainers
30 August 2021Dual-action breast cancer compounds aim to overcome common drug-resistance issues
A set of compounds developed by scientists at Scripps Research in Florida target estrogen-sensitive breast cancer cells in new ways, potentially creating better options for patients with treatment-resistant cancers.
